U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Ceftazidime – Injection products
  1. Development Resources

Ceftazidime – Injection products

Exceptions or additions to the recognized standards

For P. aeruginosa, susceptibility interpretive criteria are based on a dose of 2 grams IV every 8 hours in patients with normal renal function

For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Acinetobacter spp. disk diffusion interpretive criteria (Interpretive criteria for MIC are recognized.)

Other Non-Enterobacterales

Back to Top